Regulation & law · 08/12/2015

AMRI Rensselaer, Inc. Submits Bulk Manufacturer of Controlled Substances Application to DEA

AMRI Rensselaer, Inc. has submitted a bulk manufacturer of controlled substances application to the U.S. Drug Enforcement Administration (DEA). The company is seeking to manufacture controlled substances for distribution to licensed pharmacies and research institutions.

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Healthcare Business News Cybersecurity News Swap Clearing News Trade Regulation News CFTC Regulatory Updates Central Bank Policy News AI in Business News Small Business News Semiconductor News Supply Chain News Renewable Energy News Global Markets Business News

LATEST SIGNALS

Regulation & law · 9/14/2026

EPA Lodges Proposed Stipulation and Order of Settlement Under the Toxic Substances Control Act

The U.S. Environmental Protection Agency (EPA) has lodged a proposed stipulation and order of settlement under the Toxic Substances Control Act (TSCA) regarding a specific case.

Read summary →

Regulation & law · 9/14/2026

EPA Lodges Proposed Final Supplemental Consent Decree Under Clean Water Act

The U.S. Environmental Protection Agency (EPA) has lodged a proposed final supplemental consent decree under the Clean Water Act, addressing environmental concerns related to a specific water body.

Read summary →

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/14/2026

Irvine Labs, Inc. Applies for Controlled Substances Importer Registration

Irvine Labs, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/11/2026

Bureau of Justice Statistics Requests OMB Approval for 2026 National Survey of Victim Service Providers

The Bureau of Justice Statistics is seeking OMB approval to reinstate and modify a previously approved information collection, the 2026 National Survey of Victim Service Providers, which has expired.

Read summary →

Regulation & law · 9/11/2026

Veterinarian Craig Cohen Issues Decision and Order Regarding Animal Welfare

Veterinarian Craig Cohen, DPM, has made a decision and order regarding animal welfare, but no further details are available.

Read summary →